Market Closed -
Other stock markets
|
Pre-market 07:24:31 am | |||
3.15 USD | -8.43% | 3.165 | +0.48% |
Financials (USD)
Sales 2024 * | 14.8M | Sales 2025 * | 19.28M | Capitalization | 3.63M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | - | EV / Sales 2024 * | 0.25 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.19 x |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
3.6
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
Latest transcript on NovaBay Pharmaceuticals, Inc.
1 day | +0.48% | ||
1 week | -31.71% | ||
Current month | -8.43% | ||
1 month | -5.16% | ||
3 months | -40.98% | ||
6 months | -70.64% | ||
Current year | -55.88% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 02-04-30 |
Yen You Zheng
BRD | Director/Board Member | 67 | 19-09-10 |
Bob Wu
BRD | Director/Board Member | 49 | 16-01-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 3.15 | -8.43% | 173,835 |
24-05-31 | 3.44 | -5.68% | 314,914 |
24-05-30 | 3.647 | -36.11% | 572,721 |
24-05-29 | 5.708 | +15.67% | 1,408,562 |
Delayed Quote Nyse, June 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.88% | 3.63M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+38.79% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- NBY Stock